| 英文名称 |
中文名称 |
CAS号 |
操作 |
| Ursulcholic acid |
熊硫胆酸 |
88426-32-8 |
详细
|
| PH-797804 |
PH-797804 |
586379-66-0 |
详细
|
| UNC1999 |
UNC1999 |
1431612-23-5 |
详细
|
| RS-1 |
4-溴-N-(4-溴苯基)-3-[[(苯基甲基)氨基]磺酰基]苯甲酰胺 |
312756-74-4 |
详细
|
| PI-3065 |
PI-3065 |
955977-50-1 |
详细
|
| Tenofovir alafenamide fumarate (1:1 salt) |
替诺福韦阿拉芬酰胺富马酸酯 |
379270-38-9 |
详细
|
| THZ1 |
THZ1 |
1604810-83-4 |
详细
|
| PF-06463922 |
劳拉替尼 |
1454846-35-5 |
详细
|
| Selonsertib |
SELONSERTIB |
1448428-04-3 |
详细
|
| SCH772984 |
(R)-1-(2--2-氧(4-(4-(嘧啶-2-基)苯基)对二氮己环-1-基)乙基)-N-(3-(吡啶-4-基)-1H--5INDAZOL-基)吡咯烷-3-甲酰胺 |
942183-80-4 |
详细
|
| PCI 24781 |
PCI-24781 |
783355-60-2 |
详细
|
| TAK-700 |
TAK-700 (ORTERONEL) |
426219-18-3 |
详细
|
| SEA-0400 |
2-[4-[(2,5-二氟苯基)甲氧基]苯氧基]-5-乙氧基苯胺 |
223104-29-8 |
详细
|
| STF-31 |
4-((4-(叔丁基)苯基磺酰胺基)甲基)-N-(吡啶-3-基)苯甲酰胺 |
724741-75-7 |
详细
|
| RTA-408 |
NRF1-ACTIVATOR-1 |
1474034-05-3 |
详细
|
| Tenofovir alafenamide fumarate |
替诺福韦艾拉酚胺富马酸盐 |
1392275-56-7 |
详细
|
| PD-L1 inhibitor 1 |
PD1-PDL1抑制剂2 |
1675203-84-5 |
详细
|
| Rbin-1 |
RBIN-1 |
328023-11-6 |
详细
|
| Vamorolone |
地塞米松EP杂质E |
13209-41-1 |
详细
|
| Obatoclax mesilate |
Obatoclax 甲磺酸盐 |
803712-79-0 |
详细
|
| TAS-103 |
TAS 103 |
174634-08-3 |
详细
|
| PF-04691502 |
2-氨基-8-[反式-4-(2-羟基乙氧基)环己基]-6-(6-甲氧基-3-吡啶基)-4-甲基吡啶并[2,3-D]嘧啶-7(8H)-酮 |
1013101-36-4 |
详细
|
| PFI-1 |
PFI-1 (PF-6405761) |
1403764-72-6 |
详细
|
| TUG 891 |
TUG 891 |
1374516-07-0 |
详细
|
| UNC2025 |
反式-4-[2-(丁基氨基)-5-[4-[(4-甲基-1-哌嗪基)甲基]苯基]-7H-吡咯并[2,3-D]嘧啶-7-基]-环己醇 |
1429881-91-3 |
详细
|
| Pexidartinib |
培西达替尼 |
1029044-16-3 |
详细
|
| SR9243 |
N-[2-(3-溴苯基)乙基]-2,4,6-三甲基-N-[[3'-(甲基磺酰基)[1,1'-联苯]-4-基]甲基]苯磺酰胺 |
1613028-81-1 |
详细
|
| NSC-12 |
CS-2161 |
102586-30-1 |
详细
|
| PF-00562271(PF-562271) |
|
939791-39-6 |
详细
|
| U-73343 |
U-73343;1-[6-[((17Β)-3-METHOXYESTRA-1,3,5[10]-TRIEN-17-YL)AMINO]HEXYL]-2,5-PYRROLIDINEDIONE |
142878-12-4 |
详细
|
| TSU-68 |
orantinib |
252916-29-3 |
详细
|
| PKI-587 |
N-[4-[[4-(二甲基氨基)-1-哌啶基]羰基]苯基]-N'-[4-[4,6-二(4-吗啉基)-1,3,5-三嗪-2-基]苯基]脲 |
1197160-78-3 |
详细
|
| Sugammadex sodium |
舒更葡糖钠 |
343306-79-6 |
详细
|
| SRT 1720 HCl |
SRT1720 |
1001645-58-4 |
详细
|
| Pluripotin |
PLURIPOTIN |
839707-37-8 |
详细
|
| TubaststinA HCl |
Tubastatin A盐酸盐 |
1310693-92-5 |
详细
|
| Silvestrol aglycone |
(1R,2R,3S,3AR,8BS)-2,3,3A,8B-四氢-1,6,8B-三羟基-8-甲氧基-3A-(4-甲氧基苯基)-3-苯基-1H-环戊并[B]苯并呋喃-2-甲酸甲酯 |
960365-65-5 |
详细
|
| Radotinib |
拉多替尼 |
926037-48-1 |
详细
|
| TM 5275 sodium salt |
CS-2524 |
1103926-82-4 |
详细
|
| SU 11274 |
N-(3-氯苯基)-N-甲基-3-[[3,5-二甲基-4-[(4-甲基哌嗪-1-基)羰基-1H-吡咯-2-基]亚甲基]-2-氧代-2,3-二氢-1H-吲哚-5-磺酰胺 |
658084-23-2 |
详细
|
| SKF-86002 |
6-(4-氟苯基)-5-(4-吡啶基)-2,3-二氢咪唑并[2,1-B]-噻唑 |
72873-74-6 |
详细
|
| SL327 |
SL 327 |
305350-87-2 |
详细
|
| SGX-523 |
SGX-523 |
1022150-57-7 |
详细
|
| Quizartinib HCl |
AC-220;AC220 |
1132827-21-4 |
详细
|
| ODM-201 |
达洛鲁胺 |
1297538-32-9 |
详细
|
| OICR9429 |
OICR-9429 |
1801787-56-3 |
详细
|
| Nutlin-3 |
REL-4-[[(4R,5S)-4,5-双(4-氯苯基)-4,5-二氢-2-[4-甲氧基-2-(1-甲基乙氧基)苯基]-1H-咪唑-1-基]羰基]-2-哌嗪酮 |
548472-68-0 |
详细
|
| Pirodavir |
吡罗达韦 |
124436-59-5 |
详细
|
| Tozasertib |
陶扎色替 |
639089-54-6 |
详细
|
| NVP-LDE225 |
索尼吉布 |
956697-53-3 |
详细
|
| SB 271046 hydrochloride |
SB271046 |
209481-20-9 |
详细
|
| Torin 1 |
1-[4-[4-(1-氧代丙基)-1-哌嗪基]-3-(三氟甲基)苯基]-9-(3-喹啉基)苯并[H]-1,6-萘啶-2(1H)-酮 |
1222998-36-8 |
详细
|
| PF-04217903 |
2-[4-[1-(喹啉-6-甲基)-1H-[1,2,3]三唑并[4,5-B]吡嗪-6-基]-1H-吡唑-1-基]乙醇 |
956905-27-4 |
详细
|
| P529 |
PALOMID 529 (P529) |
914913-88-5 |
详细
|
| TH-302 |
N,N'-双(2-溴乙基)二氨基膦酸 (1-甲基-2-硝基-1H-咪唑-5-基)甲酯 |
918633-87-1 |
详细
|
| PCI-34051 |
N-羟基-1-(4-甲氧基苄基)-1H-吲哚-6-甲酰胺 |
950762-95-5 |
详细
|
| Vipadenant |
3-(4-氨基-3-甲基苄基)-7-(呋喃-2-基)-3H-[1,2,3]三唑并[4,5-D]嘧啶-5-胺 |
442908-10-3 |
详细
|
| Ponatinib HCl |
泊那替尼盐酸盐 |
1114544-31-8 |
详细
|
| RGB-286638 |
N-[1,4-二氢-3-[4-[[4-(2-甲氧基乙基)-1-哌嗪基]甲基]苯基]-4-氧代茚并[1,2-C]吡唑-5-基]-N'-4-吗啉基脲 |
784210-88-4 |
详细
|
| TAK-632 |
TAK-632 |
1228591-30-7 |
详细
|
| SUN11602 |
化合物SUN 11602 |
704869-38-5 |
详细
|
| PF06447475 |
PF-06447475 |
1527473-33-1 |
详细
|
| RO 61-8048 |
RO 61-8048 |
199666-03-0 |
详细
|
| NVP-BSK805 |
NVP-BSK805 dihydrochloride |
1092499-93-8 |
详细
|
| PF-4136309 |
INCB8761(PF-4136309) |
1341224-83-6 |
详细
|
| RGFP966 |
RGFP966 |
1357389-11-7 |
详细
|
| USP7-USP47 inhibitor |
4-氰基-5-[(3,5-二氯-4-吡啶基)硫基]-N-[4-(甲基磺酰基)苯基]-2-噻吩甲酰胺 |
1247825-37-1 |
详细
|
| Phosphine oxide, [(2Z)-2-[(3R,4R,5R)-3,5-bis[[(1,1-diMethylethyl)diMethylsilyl]oxy]-4-[3-[[(1,1-diMethylethyl)diMethylsilyl]oxy]propoxy]-2-Methylenecyclohexylidene]ethyl]diphenyl- |
艾地骨化醇中间体A环 |
200636-54-0 |
详细
|
| PFI3 |
(2E)-1-(2-羟基苯基)-3-[(1R,4R)-5-(2-吡啶基)-2,5-二氮杂双环[2.2.1]庚-2-基]-2-丙烯-1-酮 |
1819363-80-0 |
详细
|
| PFI-2 |
PFI-2 |
1627676-59-8 |
详细
|
| TAK-063 |
1-(2-氟-4-(1H-吡唑-1-基)苯基)-5-甲氧基-3-(1-苯基-1H-吡唑-5-基)哒嗪-4(1H)-酮 |
1238697-26-1 |
详细
|
| RAF-709 |
化合物RAF709 |
1628838-42-5 |
详细
|
| Pixantrone |
匹杉琼 |
144510-96-3 |
详细
|
| Tariquidar |
N-[2-[[4-[2-(6,7-二甲氧基-3,4-二氢-1H-异喹啉-2-基)乙基]苯基]氨基甲酰基]-4,5-二甲氧基苯基]喹啉-3-甲酰胺 |
206873-63-4 |
详细
|
| TRILAURYL PHOSPHITE |
亚磷酸三(十二烷基)酯 |
3076-63-9 |
详细
|
| PQ 401 |
PQ 401 |
196868-63-0 |
详细
|
| PD 153035 hydrochloride |
4-[(3-溴苯基)氨基]-6,7-二甲氧基喹啉 |
153436-54-5 |
详细
|
| UNC1215 |
UNC1215 |
1415800-43-9 |
详细
|
| Pilaralisib |
2-氨基-N-[3-[N-[3-[(2-氯-5-甲氧基苯基)氨基]喹喔啉-2-基]氨基磺酰基]苯基]-2-甲基丙酰胺 |
934526-89-3 |
详细
|
| SHP099 |
SHP-099盐酸盐 |
1801747-11-4 |
详细
|
| SCI 208 |
SD-208 |
627536-09-8 |
详细
|
| RocaglaMide |
楝酰胺 |
84573-16-0 |
详细
|
| Pirmenol |
Pirmenol |
68252-19-7 |
详细
|
| TG101209 |
N-(1,1-二甲基乙基)-3-[[5-甲基-2-[[4-(4-甲基-1-哌嗪基)苯基]氨基]-4-嘧啶基]氨基]苯磺酰胺 |
936091-14-4 |
详细
|
| NVP-BKM-120 |
BKM-120 |
944396-07-0 |
详细
|
| Rucaparib phosphate |
瑞卡帕布（AG-014699） |
459868-92-9 |
详细
|
| SGI-1776 |
SGI-1776 |
1025065-69-3 |
详细
|
| OC000459 |
[5-氟-2-甲基-3-(喹啉-2-基甲基)吲哚-1-基]乙酸 |
851723-84-7 |
详细
|
| TIC10 |
TIC-10 |
41276-02-2 |
详细
|
| SF2523 |
SF-2523 |
1174428-47-7 |
详细
|
| SU 5416 |
SU5416 |
204005-46-9 |
详细
|
| PNU-120596 |
PNU 120596 |
501925-31-1 |
详细
|
| SB742457 |
3-苯基磺酰基-8-(哌嗪-1-基)喹啉 |
607742-69-8 |
详细
|
| PHA-848125 |
PHA-848125 |
802539-81-7 |
详细
|
| SQ109 |
SQ 109 |
502487-67-4 |
详细
|
| SH-4-54 |
SH-4-54 |
1456632-40-8 |
详细
|
| TP-3654 |
TP3654 |
1361951-15-6 |
详细
|
| RR6 |
1351758-37-6 |
1351758-37-6 |
详细
|